Prognostic Value of Plasma Biomarkers Among Patients With Hypertension (BIOMS-HTN)

Beijing Institute of Heart, Lung and Blood Vessel Diseases

Status: Unknown

Conditions: Hypertension

Study type: Observational

Funder types: Other

Identifiers

NCT04107584

HTN2019

Details and patient eligibility

About

Hypertension is the most important risk factor for cardiovascular and cerebrovascular diseases，and also a substantial public health problem. The purpose of the study is to investigate the association between plasma biomarkers and adverse outcomes in patients with hypertension.

Enrollment: 600 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• >18 years old
• In accordance with the diagnosis of hypertension (BP≥140/90mmHg)

Exclusion criteria

• The exclusion Criteria for the study program were as follows:

Pregnancy, history of heart failure or left ventricular ejection fraction less than 40%, myocardial infarction within one month, percutaneous transluminal coronary angioplasty or coronary artery bypass grafting, cerebrovascular disease, severe liver disease, severe chronic renal failure (eGFR less than 30 mL/min/1.73 m2) in the past three months.